Association Between Metabolic Syndrome and All-Cause Mortality in Patients with Acute Coronary Syndrome: A Meta-Analysis

Abstract

The association between metabolic syndrome (MetS) and survival outcome after acute coronary syndrome (ACS) remains controversial. This meta-analysis sought to examine the association of MetS with all-cause mortality among patients with ACS. Two authors independently searched PubMed and Embase databases (from their inception to June 27, 2020) for studies that examined the association of MetS with all-cause mortality among patients with ACS. Outcome measures were in-hospital mortality and all-cause mortality during the follow-up. A total of 10 studies involving 49 896 ACS patients were identified. Meta-analysis indicated that presence of MetS was associated with an increased risk of long-term all-cause mortality [risk ratio (RR) 1.25; 95% CI 1.15–1.36; n=9 studies] and in-hospital mortality (RR 2.35; 95% CI 1.40–3.95; n=2 studies), respectively. Sensitivity and subgroup analysis demonstrated the credibility of the value of MetS in predicting long-term all-cause mortality. MetS is associated with an increased risk of long-term all-cause mortality among patients with ACS. However, additional studies are required to investigate the association of MetS with in-hospital mortality.

Key words

metabolic syndrome - acute coronary syndrome - in-hospital mortality - all-cause mortality

Publikationsverlauf

Eingereicht: 05. Juli 2020

Angenommen nach Revision: 29. Januar 2021

Artikel online veröffentlicht:
10. März 2021

• References

• 1 Grech ED, Ramsdale DR. Acute coronary syndrome: Unstable angina and non-ST segment elevation myocardial infarction. BMJ 2003; 326: 1259-1261
• 2 Piironen M, Ukkola O, Huikuri H. et al. Trends in long-term prognosis after acute coronary syndrome. Eur J Prev Cardiol 2017; 24: 274-280
• 3 DeBoer MD, Gurka MJ, Morrison JA. et al. Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease. Int J Obes (Lond) 2016; 40: 1353-1359
• 4 Tie HT, Shi R, Li ZH. et al. Risk of major adverse cardiovascular events in patients with metabolic syndrome after revascularization: A meta-analysis of eighteen cohorts with 18 457 patients. Metabolism 2015; 64: 1224-1234
• 5 Al Suwaidi J, Zubaid M, El-Menyar AA. et al. Prevalence of the metabolic syndrome in patients with acute coronary syndrome in six middle eastern countries. J Clin Hypertens (Greenwich) 2010; 12: 890-899
• 6 Alakkas Z, Alswat KA, Otaibi MA. et al. The prevalence and the clinical characteristics of metabolic syndrome patients admitted to the cardiac care unit. J Saudi Heart Assoc 2016; 28: 136-143
• 7 Levantesi G, Macchia A, Marfisi R. et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 2005; 46: 277-283
• 8 Takeno M, Yasuda S, Otsuka Y. et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: Potential association with C-reactive protein. Circ J 2008; 72: 415-419
• 9 Dohi T, Miyauchi K, Kasai T. et al. Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome. Circ J 2009; 73: 1454-1458
• 10 Lee MG, Jeong MH, Ahn Y. et al. Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction. J Korean Med Sci 2010; 25: 1456-1461
• 11 Hoshida S, Teragaki M, Lim YJ. et al. Admission with metabolic disorder is a useful predictor of the 1-year prognosis for patients with unstable angina, but not for patients with acute myocardial infarction: east-Osaka acute coronary syndrome registry. Coron Artery Dis 2011; 22: 416-420
• 12 Kim CS, Choi JS, Bae EH. et al. Association of metabolic syndrome and renal insufficiency with clinical outcome in acute myocardial infarction. Metabolism 2013; 62: 669-676
• 13 Liberati A, Altman DG, Tetzlaff J. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1-e34
• 14 Wells G, Shea B, O'Connell D. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Assessed January 14, 2021)
• 15 Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101
• 16 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
• 17 Mehta RH, Westerhout CM, Zheng Y. et al. Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes. Am Heart J 2014; 168: 182-188 e181
• 18 Arbel Y, Havakuk O, Halkin A. et al. Relation of metabolic syndrome with long-term mortality in acute and stable coronary disease. Am J Cardiol 2015; 115: 283-287
• 19 Lovic MB, Djordjevic DB, Tasic IS. et al. Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation. Hellenic J Cardiol 2018; 59: 226-231
• 20 Cavallari I, Cannon CP, Braunwald E. et al. Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome. Eur J Prev Cardiol 2018; 25: 830-838
• 21 Wu SH, Liu Z, Ho SC. Metabolic syndrome and all-cause mortality: A meta-analysis of prospective cohort studies. Eur J Epidemiol 2010; 25: 375-384
• 22 Ju SY, Lee JY, Kim DH. Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: A meta-analysis of prospective cohort studies. Medicine (Baltimore) 2017; 96: e8491
• 23 Zeller M, Steg PG, Ravisy J. et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005; 165: 1192-1198
• 24 Celik T, Turhan H, Kursaklioglu H. et al. Impact of metabolic syndrome on myocardial perfusion grade after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction. Coron Artery Dis 2006; 17: 339-343
• 25 Feinberg MS, Schwartz R, Tanne D. et al. Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol 2007; 99: 667-672